EUVIMEDEUVIMED entdecken
Fallbericht

Low-level NLRP3 mosaicism in chronic urticarial lesions: extending the phenotypic spectrum of NLRP3 -related disorders and therapeutic implications

Aphrodite Daskalopoulou, Eman Assrawi, Farah Diab, Camille Louvrier, Maxime Samson, William Piterboth, Berengere Cador-Rousseau, Sébastien Henno, Marie Legendre, Dan Lipsker, Serge Amselem, Sonia A Karabina und 1 weitere

British Journal of Dermatology · 17.10.2025 · 193 (5) · 914-923

DOI: 10.1093/bjd/ljaf220 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Dermatology, online erschienen am 10.06.2025. Verfasst von Aphrodite Daskalopoulou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM UMR_S933, Maladies Génétiques d'Expression Pédiatrique, Hôpital Trousseau, Paris, France. Hauptthemen laut MEDLINE: Chronic Urticaria, Mosaicism, NLR Family, Pyrin Domain-Containing 3 Protein, Urticaria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: European Union's, European Union’s.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic urticarial lesions, a common condition of mostly unknown cause, can occur in immune dysregulation disorders such as hypocomplementaemic urticarial vasculitis syndrome (HUVS), neutrophilic urticarial dermatosis (NUD) and systemic autoinflammatory diseases (SAIDs), including Schnitzler syndrome.

Objectives

To identify the molecular basis of nonpruritic chronic urticarial eruptions in four unrelated patients initially diagnosed with neonatal NUD, Schnitzler syndrome, HUVS or giant-cell arteritis.

Methods

Conventional next-generation sequencing (NGS) of leucocyte DNA was supplemented with high-depth NGS (> 1500×) to improve the detection of low-level mosaicism in SAID-related genes. Functional assays were performed on recombinant NLRP3 proteins to assess the impact of the identified variations on the nuclear factor-κB (NF-κB) pathway.

Results

One patient presented with persistent isolated urticarial lesions since birth, while the other three experienced late-onset skin lesions. In contrast to the initially suspected diagnoses, conventional NGS revealed NLRP3 mosaicism in two patients, with variant allele fractions (VAFs) of 5% and 11%, respectively. In the other two patients, high-depth NGS uncovered NLRP3 mosaicism with VAFs as low as 2–3%. All identified variations activated the NF-κB pathway, demonstrating a gain-of-function effect. Subsequent anti-interleukin-1 therapy led to symptom improvement for all patients.

Conclusions

This study highlights the importance of considering NLRP3 mosaicism as an underlying pathological mechanism in chronic urticarial lesions, whether of early or late onset, and whether isolated or mimicking other conditions. As blood contains key target cells for NLRP3 inflammasome activation, even extremely low-level leucocyte mosaicism can be pathogenic. High-depth NGS-based diagnosis of NLRP3-related disorders enables timely initiation of anti-IL-1 therapy, which is crucial to preventing complications such as systemic amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic UrticariaMosaicismNLR Family, Pyrin Domain-Containing 3 ProteinUrticariaHumansCryopyrin-Associated Periodic SyndromesHigh-Throughput Nucleotide SequencingNF-kappa BPhenotypeSchnitzler Syndrome

Substanzen

NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, human

Autor:innen und Institutionen

  • Sorbonne Université, INSERM UMR_S933, Maladies Génétiques d'Expression Pédiatrique, Hôpital Trousseau, Paris, France.
  • UF de Génétique Moléculaire, Assistance Publique-Hopitaux de Paris, Hôpital Trousseau, Paris, France.
  • Service de Médecine Interne et Immunologie Clinique, Hôpital du Bocage, CHU-Dijon, Dijon, France.
  • Service de Médecine Interne, Hôpital Sud, CHU de Rennes, Rennes, France.
  • Service d'Anatomie et Cytologie Pathologiques, Hôpital Pontchaillou, CHU de Rennes, Rennes, France.
  • Faculté de Médecine, Université de Strasbourg et Clinique Dermatologique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

ORCID-Profile: Irina Giurgea

Förderung

  • European Union's
  • European Union’s

Zitieren

APA

Daskalopoulou, A., Assrawi, E., Diab, F., Louvrier, C., Samson, M., Piterboth, W., Cador-Rousseau, B., Henno, S., Legendre, M., Lipsker, D., Amselem, S., Karabina, S. A., & Giurgea, I. (2025). Low-level NLRP3 mosaicism in chronic urticarial lesions: extending the phenotypic spectrum of NLRP3 -related disorders and therapeutic implications. British Journal of Dermatology, 193(5), 914-923. https://doi.org/10.1093/bjd/ljaf220

Vancouver

Daskalopoulou A, Assrawi E, Diab F, Louvrier C, Samson M, Piterboth W, et al. Low-level NLRP3 mosaicism in chronic urticarial lesions: extending the phenotypic spectrum of NLRP3 -related disorders and therapeutic implications. British Journal of Dermatology. 2025;193(5):914-923. doi:10.1093/bjd/ljaf220

BibTeX
@article{Daskalopoulou2025,
  author = {Daskalopoulou, Aphrodite and Assrawi, Eman and Diab, Farah and Louvrier, Camille and Samson, Maxime and Piterboth, William and Cador-Rousseau, Berengere and Henno, Sébastien and Legendre, Marie and Lipsker, Dan and Amselem, Serge and Karabina, Sonia A and Giurgea, Irina},
  title = {Low-level NLRP3 mosaicism in chronic urticarial lesions: extending the phenotypic spectrum of NLRP3 -related disorders and therapeutic implications},
  journal = {British Journal of Dermatology},
  year = {2025},
  volume = {193},
  number = {5},
  pages = {914--923},
  doi = {10.1093/bjd/ljaf220}
}
Kostenlos starten →